dr. freedland on real-world utility of enzalutamide in prostate cancer
Published 4 years ago • 462 plays • Length 0:53Download video MP4
Download video MP3
Similar videos
-
1:08
dr. freedland on the importance of conducting real-world analyses in prostate cancer
-
1:08
dr. freedland on real-world evidence vs prevail trial in mcrpc
-
13:24
enzalutamide approved for prostate cancer with biochemical recurrence: stephen freedland, md
-
1:14
dr. dreicer on abiraterone and enzalutamide in prostate cancer
-
1:30
dr. freedland on diet and lifestyle interventions in patients with prostate cancer
-
1:14
dr. freedland on standardized psa testing in prostate cancer
-
1:03
dr. daniel petrylak on the role of enzalutamide in prostate cancer
-
1:47
dr. hussain on potential of enzalutamide in prostate cancer
-
1:03
dr. azad on the benefit of adding enzalutamide to adt in mhspc
-
1:31
dr. stephen freedland describes treating early-stage prostate cancer
-
0:44
dr. gomella on enzalutamide in prostate cancer
-
1:12
dr. dreicer on the current role of abiraterone and enzalutamide in prostate cancer
-
1:46
dr. agarwal on the qol with apalutamide in metastatic castration-sensitive prostate cancer
-
1:24
dr. stenzl on the safety profile of enzalutamide/adt in mhspc
-
0:59
dr. crawford on abiraterone versus enzalutamide in prostate cancer
-
18:58
talapro-2 study of talazoparib/enzalutamide in prostate cancer: stephen freedland and neeraj agarwal
-
6:40
updated overall survival outcomes in enzamet (anzup 1304)
-
1:50
dr. kohli on the use of enzalutamide and apalutamide in mhspc
-
1:06
dr. bradley on adverse events associated with enzalutamide and apalutamide in prostate cancer